Latest Sanofi Stories
OTTAWA, May 6, 2014 /CNW/ - Health Canada today released the April 2014 issue of the Canadian Adverse Reaction Newsletter (CARN). This issue features an article on the risk
LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
PARIS, April 29, 2014 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2014 Change (reported) Change (CER) Net sales EUR7,842m
PARIS, April 29, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first-quarter of 2014.
LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Loyalty Buyback Program Allows Customers to Sell their Excess IT Hardware to Aventis Systems for Cash or Aventis Bucks Credit ATLANTA, April 23, 2014 /PRNewswire/ -- Aventis Systems,
Market Access Challenges for Sanofi/Genzyme's Aubagio Highlight the Hurdles New Multiple Sclerosis Agents Face in Europe, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Nasal allergy sufferers now have the most effective player on their team to relieve even the toughest nasal allergy symptoms CHATTANOOGA, Tenn., April 15, 2014 /PRNewswire/ -- Nancy
Editor Note: For more information about this release, please scroll to bottom. LONDON, April 8, 2014 /PRNewswire/ -- The trading session on Monday, April 07, 2014
- Data Advances microRNA Oncology Portfolio - LA JOLLA, Calif., April 7, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.
- totally perplexed and mixed up.